Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
254 participants
INTERVENTIONAL
2010-01-31
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. the transfused red blood cells' ability to delivery oxygen to the tissues
2. differences in biochemical markers in subjects and units transfused, and
3. how the subject's internal organs are working and if they develop any infections
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low-Titer O Positive Whole Blood Versus Component Therapy for Emergent Transfusion in Trauma Patients
NCT05081063
Adverse Effects of RBC Transfusions: A Unifying Hypothesis
NCT00838331
Effect of Leukoreduced Blood Transfusions on Infection Following Trauma
NCT00135291
Early Whole Blood in Patients Requiring Transfusion After Major Trauma
NCT01227005
Adverse Effects of Red Blood Cell Transfusions: A Unifying Hypothesis (Aim 3)
NCT02280655
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Refrigerated RBCs 0-14 days old
Standard, refrigerated RBC units stored up to 14 days
RBC units
When a transfusion is ordered, enrolled subjects will receive RBC units 1) up to 14 days old, 2) 14-42 days old, or 3) that are frozen when stored.
Refrigerated RBCs 15-42 days old
Standard, refrigerated RBC units stored 15-42 days
RBC units
When a transfusion is ordered, enrolled subjects will receive RBC units 1) up to 14 days old, 2) 14-42 days old, or 3) that are frozen when stored.
Frozen RBCs
RBC units stored frozen at -80 degrees Celsius, then thawed and deglycerolized using the ACP 215.
RBC units
When a transfusion is ordered, enrolled subjects will receive RBC units 1) up to 14 days old, 2) 14-42 days old, or 3) that are frozen when stored.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RBC units
When a transfusion is ordered, enrolled subjects will receive RBC units 1) up to 14 days old, 2) 14-42 days old, or 3) that are frozen when stored.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Require a blood (PRBC) transfusion
* Transfusion is not emergent
* Able to obtain consent from patient or appropriate 3rd party prior to 1st transfusion
Exclusion Criteria
* Bilateral hand injuries that prevent StO2 measurements
* Age \< 15
* Pregnancy
* Massive transfusion (=/\> 10 units in 24 hours) in last 3 months
* Hemodynamically unstable or need for transfusion in \< 3 hours
15 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Air Force
FED
Armed Services Blood Program
UNKNOWN
Oregon Health and Science University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Martin A Schreiber, MD
Professor & Chief of Trauma
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin Schreiber, MD
Role: PRINCIPAL_INVESTIGATOR
Oregon Health and Science University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Cincinnati
Cincinnati, Ohio, United States
Oregon Health & Science University
Portland, Oregon, United States
University of Texas Southwestern Medical Center
Dallas, Texas, United States
University of Texas Health Science Center at Houston
Houston, Texas, United States
University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
002-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.